8-K Announcements
6Apr 9, 2026·SEC
Apr 3, 2026·SEC
Mar 25, 2026·SEC
Mobix Labs, Inc. (MOBX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant strengths identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Mobix Labs, Inc. (MOBX) stock price & volume — 10-year historical chart
Mobix Labs, Inc. (MOBX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Mobix Labs, Inc. (MOBX) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 12, 2026 | $1.60 | $2M |
| Q1 2026 | Jan 12, 2026 | $2.90 | $2Mvs $2M+0.0% |
| Q3 2025 | Aug 13, 2025 | $0.17 | $2Mvs $2M+0.0% |
| Q2 2025 | May 15, 2025 | $0.06 | $3M |
Mobix Labs, Inc. (MOBX) competitors in Optical, Photonics and Display Components — business model, growth, and fundamentals comparison
Mobix Labs, Inc. (MOBX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Mobix Labs, Inc. (MOBX) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|
| Sales/Revenue | 435K | 3.31M | 1.22M | 6.44M | 9.91M | 8.62M |
| Revenue Growth % | - | 660.69% | -63.01% | 426.31% | 53.87% | -7.59% |
| Cost of Goods Sold | 297K | 2.85M | 1.62M | 3.89M | 4.91M | 4.72M |
| COGS % of Revenue | 68.28% | 86.19% | 132.35% | 60.38% | 49.49% | - |
| Gross Profit | 138K▲ 0% | 457K▲ 231.2% | -396K▼ 186.7% | 2.55M▲ 744.4% | 5.01M▲ 96.2% | 3.9M▲ 0% |
| Gross Margin % | 31.72% | 13.81% | -32.35% | 39.62% | 50.51% | 45.27% |
| Gross Profit Growth % | - | 231.16% | -186.65% | 744.44% | 96.2% | - |
| Operating Expenses | 21.87M | 24.17M | 35.15M | 48.95M | 48.58M | 44.32M |
| OpEx % of Revenue | 5027.13% | 730.46% | 2871.57% | 759.81% | 490.09% | - |
| Selling, General & Admin | 5.75M | 11.98M | 24.1M | 41.84M | 46.16M | 41.35M |
| SG&A % of Revenue | 1321.15% | 361.98% | 1969.28% | 649.41% | 465.69% | - |
| Research & Development | 7.69M | 12.19M | 11.04M | 5.78M | 2.42M | 2.25M |
| R&D % of Revenue | 1767.13% | 368.48% | 902.29% | 89.71% | 24.4% | - |
| Other Operating Expenses | 8.43M | 0 | 0 | 1.33M | 0 | 725K |
| Operating Income | -21.73M▲ 0% | -23.71M▼ 9.1% | -35.54M▼ 49.9% | -46.4M▼ 30.5% | -43.57M▲ 6.1% | -40.42M▲ 0% |
| Operating Margin % | -4995.4% | -716.65% | -2903.92% | -720.2% | -439.58% | -469.05% |
| Operating Income Growth % | - | -9.13% | -49.89% | -30.53% | 6.09% | - |
| EBITDA | -21M | -22.35M | -34.25M | -44.38M | -41.51M | -38.5M |
| EBITDA Margin % | -4828.05% | -675.31% | -2798.53% | -688.92% | -418.82% | -446.79% |
| EBITDA Growth % | - | -6.4% | -53.29% | -29.56% | 6.46% | 65.58% |
| D&A (Non-Cash Add-back) | 728K | 1.37M | 1.29M | 2.02M | 2.06M | 1.92M |
| EBIT | -21.73M | -23.8M | -36.2M | -20.88M | -43.8M | -33.33M |
| Net Interest Income | -239K | -343K | -3.35M | -1.58M | -2.33M | -3.49M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 239K | 343K | 3.35M | 1.58M | 2.33M | 3.49M |
| Other Income/Expense | -239K | -426K | -4.01M | 23.93M | -2.55M | 3.99M |
| Pretax Income | -21.97M▲ 0% | -24.14M▼ 9.9% | -39.55M▼ 63.9% | -22.46M▲ 43.2% | -46.12M▼ 105.3% | -36.43M▲ 0% |
| Pretax Margin % | -5050.34% | -729.53% | -3231.54% | -348.7% | -465.33% | -422.74% |
| Income Tax | -1.98M | -273K | 67K | -2.43M | 7K | -15K |
| Effective Tax Rate % | 9% | 1.13% | -0.17% | 10.81% | -0.02% | 0.04% |
| Net Income | -19.99M▲ 0% | -23.87M▼ 19.4% | -39.62M▼ 66.0% | -20.03M▲ 49.4% | -46.13M▼ 130.3% | -36.42M▲ 0% |
| Net Margin % | -4595.63% | -721.28% | -3237.01% | -310.99% | -465.41% | -422.57% |
| Net Income Growth % | - | -19.39% | -66.01% | 49.44% | -130.26% | 10.76% |
| Net Income (Continuing) | -19.99M | -23.87M | -39.62M | -20.03M | -46.13M | -36.42M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -7.00▲ 0% | -20.00▼ 185.7% | -13.80▲ 31.0% | -5.90▲ 57.2% | -10.10▼ 71.2% | -8.01▲ 0% |
| EPS Growth % | - | -185.71% | 31% | 57.25% | -71.19% | 41.39% |
| EPS (Basic) | -32.30 | -20.00 | -13.80 | -7.30 | -10.10 | - |
| Diluted Shares Outstanding | 1M | 1.2M | 1.46M | 3.5M | 4.55M | 4.55M |
| Basic Shares Outstanding | 1M | 1.19M | 1.46M | 2.84M | 4.55M | 4.55M |
| Dividend Payout Ratio | - | - | - | - | - | - |
Mobix Labs, Inc. (MOBX) balance sheet — assets, liabilities & shareholders' equity
| Line item | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|
| Total Current Assets | 3.64M | 1.98M | 830K | 5.27M | 6.71M | 2.87M |
| Cash & Short-Term Investments | 1.01M | 178K | 89K | 266K | 3.27M | 268K |
| Cash Only | 1.01M | 178K | 89K | 266K | 3.27M | 268K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 2.2M | 561K | 53K | 2.81M | 1.41M | 1.02M |
| Days Sales Outstanding | 1.85K | 61.88 | 15.8 | 159.38 | 52.07 | 59.22 |
| Inventory | 232K | 570K | 319K | 1.73M | 1.44M | 1.17M |
| Days Inventory Outstanding | 285.12 | 72.95 | 71.87 | 161.86 | 106.78 | 95.87 |
| Other Current Assets | 191K | 667K | 369K | 467K | 593K | 417K |
| Total Non-Current Assets | 15.25M | 13.51M | 17.92M | 33.82M | 30.4M | 29.85M |
| Property, Plant & Equipment | 2.86M | 1.76M | 2.89M | 2.2M | 698K | 557K |
| Fixed Asset Turnover | 0.15x | 1.88x | 0.42x | 2.93x | 14.20x | 9.59x |
| Goodwill | 5.22M | 5.22M | 5.22M | 16.07M | 16.07M | 16.07M |
| Intangible Assets | 6.97M | 6.13M | 5.29M | 15.21M | 13.52M | 13.11M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 200K | 400K | 4.53M | 341K | 115K | 944K |
| Total Assets | 18.88M▲ 0% | 15.48M▼ 18.0% | 18.75M▲ 21.1% | 39.09M▲ 108.5% | 37.11M▼ 5.1% | 32.72M▲ 0% |
| Asset Turnover | 0.02x | 0.21x | 0.07x | 0.16x | 0.27x | 0.24x |
| Asset Growth % | - | -18% | 21.08% | 108.49% | -5.05% | -9.68% |
| Total Current Liabilities | 16.35M | 21.96M | 20.42M | 26.11M | 27.79M | 25.24M |
| Accounts Payable | 3.08M | 5.09M | 8.99M | 10.83M | 8.98M | 7.94M |
| Days Payables Outstanding | 3.79K | 652.06 | 2.03K | 1.02K | 668.31 | 773.82 |
| Short-Term Debt | 3.41M | 5.68M | 6.59M | 2.14M | 5.09M | 4.35M |
| Deferred Revenue (Current) | 0 | 0 | 138K | 1.08M | 1.05M | 2.84M |
| Other Current Liabilities | 9.5M | 10.63M | 3.8M | 6.37M | 6.74M | 12.71M |
| Current Ratio | 0.22x | 0.09x | 0.04x | 0.20x | 0.24x | 0.24x |
| Quick Ratio | 0.21x | 0.06x | 0.03x | 0.14x | 0.19x | 0.19x |
| Cash Conversion Cycle | -1.66K | -517.23 | -1.94K | -695.22 | -509.46 | -618.72 |
| Total Non-Current Liabilities | 2.59M | 2.94M | 3.67M | 7.45M | 9.66M | 2.81M |
| Long-Term Debt | 0 | 625K | 0 | 1.28M | 1.1M | 1.96M |
| Capital Lease Obligations | 0 | 0 | 1.28M | 1.02M | 96K | 1.69M |
| Deferred Tax Liabilities | 294K | 20K | 86K | 320K | 321K | 1.23M |
| Other Non-Current Liabilities | 2.3M | 2.3M | 2.3M | 4.83M | 8.15M | 16.71M |
| Total Liabilities | 18.95M | 24.9M | 24.09M | 33.56M | 37.45M | 28.06M |
| Total Debt | 3.41M | 6.3M | 8.19M | 4.88M | 6.55M | 6.59M |
| Net Debt | 2.4M | 6.12M | 8.1M | 4.61M | 3.28M | 6.32M |
| Debt / Equity | - | - | - | 0.88x | - | 1.41x |
| Debt / EBITDA | - | - | - | - | - | -0.17x |
| Net Debt / EBITDA | - | - | - | - | - | -0.16x |
| Interest Coverage | -90.92x | -69.38x | -10.79x | -13.20x | -18.84x | -9.54x |
| Total Equity | -63K▲ 0% | -9.42M▼ 14850.8% | -5.34M▲ 43.3% | 5.53M▲ 203.5% | -336K▼ 106.1% | 4.67M▲ 0% |
| Equity Growth % | - | -14850.79% | 43.3% | 203.54% | -106.08% | -39.29% |
| Book Value per Share | -0.06 | -7.88 | -3.65 | 1.58 | -0.07 | 1.03 |
| Total Shareholders' Equity | -63K | -9.42M | -5.34M | 5.53M | -336K | 4.67M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -20.27M | -44.14M | -83.76M | -104.46M | -150.59M | -160.71M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Mobix Labs, Inc. (MOBX) cash flow — operating, investing & free cash flow history
| Line item | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|
| Cash from Operations | -10.94M | -321.01K | -14.63M | -18.39M | -10.11M | -10.11M |
| Operating CF Margin % | -2515.17% | -9.7% | -1194.93% | -285.44% | -102.03% | - |
| Operating CF Growth % | - | 97.07% | -4456.27% | -25.72% | 45% | -376.92% |
| Net Income | -19.99M | -776.13K | -39.62M | -20.03M | -46.13M | -36.42M |
| Depreciation & Amortization | 728K | 0 | 1.29M | 2.02M | 2.06M | 1.92M |
| Stock-Based Compensation | 307K | 0 | 15.48M | 21.38M | 25.62M | 20.96M |
| Deferred Taxes | -1.98M | 0 | 66K | -2.43M | 1K | -22K |
| Other Non-Cash Items | 8.43M | -266.73K | 3.52M | -24.17M | 6.97M | 2.27M |
| Working Capital Changes | 1.56M | 721.85K | 4.64M | 4.85M | 1.37M | -2.65M |
| Change in Receivables | -47K | 0 | 385K | -1.82M | 1.43M | 764K |
| Change in Inventory | 84K | 0 | 251K | -105K | 290K | 73K |
| Change in Payables | 1.26M | 0 | 1.39M | 3.86M | -1.28M | -2.19M |
| Cash from Investing | -1.39M | 70.17M | -633K | -1.11M | 1K | 1K |
| Capital Expenditures | -1.45M | -56K | 0 | -44K | -26K | 1K |
| CapEx % of Revenue | 332.64% | 1.69% | - | 0.68% | 0.26% | - |
| Acquisitions | 53K | 0 | -633K | -1.06M | 27K | 0 |
| Investments | - | - | - | - | - | - |
| Other Investing | 0 | 70.57M | 0 | 0 | 0 | 0 |
| Cash from Financing | 13.07M | -69.91M | 15.17M | 19.67M | 13.12M | 13.81M |
| Debt Issued (Net) | 0 | 662K | 1.68M | -1.56M | 3.53M | 3.34M |
| Equity Issued (Net) | 11.27M | -70.57M | 13.51M | 3.58M | 3.65M | 4.35M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -70.57M | 0 | 0 | 0 | 0 |
| Other Financing | 1.8M | 0 | -24K | 17.65M | 5.95M | 6.12M |
| Net Change in Cash | 733K▲ 0% | -64.92K▼ 108.9% | -89K▼ 37.1% | 177K▲ 298.9% | 3.01M▲ 1598.9% | -137K▲ 0% |
| Free Cash Flow | -12.39M▲ 0% | -321.01K▲ 97.4% | -14.63M▼ 4456.2% | -18.43M▼ 26.0% | -10.14M▲ 45.0% | -13.97M▲ 0% |
| FCF Margin % | -2847.82% | -9.7% | -1194.93% | -286.12% | -102.29% | -162.15% |
| FCF Growth % | - | 97.41% | -4456.24% | -26.02% | 44.99% | 11.34% |
| FCF per Share | -12.38 | -0.27 | -10.01 | -5.27 | -2.23 | -2.23 |
| FCF Conversion (FCF/Net Income) | 0.55x | 0.01x | 0.37x | 0.92x | 0.22x | 0.38x |
| Interest Paid | 0 | 0 | 0 | 521K | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 |
Mobix Labs, Inc. (MOBX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -21200% | -1776.32% | -2857.36% |
| Return on Invested Capital (ROIC) | - | -966.22% | -539.56% | -499.48% | -499.48% |
| Gross Margin | 13.81% | -32.35% | 39.62% | 50.51% | 45.27% |
| Net Margin | -721.28% | -3237.01% | -310.99% | -465.41% | -422.57% |
| Debt / Equity | - | - | 0.88x | - | 1.41x |
| Interest Coverage | -69.38x | -10.79x | -13.20x | -18.84x | -9.54x |
| FCF Conversion | 0.01x | 0.37x | 0.92x | 0.22x | 0.38x |
| Revenue Growth | 660.69% | -63.01% | 426.31% | 53.87% | -7.59% |
Mobix Labs, Inc. (MOBX) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 9, 2026·SEC
Apr 3, 2026·SEC
Mar 25, 2026·SEC
Mobix Labs, Inc. (MOBX) stock FAQ — growth, dividends, profitability & financials explained
Mobix Labs, Inc. (MOBX) reported $8.6M in revenue for fiscal year 2025. This represents a 1881% increase from $0.4M in 2021.
Mobix Labs, Inc. (MOBX) grew revenue by 53.9% over the past year. This is strong growth.
Mobix Labs, Inc. (MOBX) reported a net loss of $36.4M for fiscal year 2025.
Mobix Labs, Inc. (MOBX) has a return on equity (ROE) of -1776.3%. Negative ROE indicates the company is unprofitable.
Mobix Labs, Inc. (MOBX) had negative free cash flow of $14.0M in fiscal year 2025, likely due to heavy capital investments.
Mobix Labs, Inc. (MOBX) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates